SOURCE: IBC Life Sciences

January 09, 2007 14:00 ET

IBC's 18th International Antibody Development & Production Conference

Providing Successful Upstream & Downstream Processing Approaches

WESTBOROUGH, MA -- (MARKET WIRE) -- January 9, 2007 -- IBC Life Sciences is pleased to be returning to the La Costa Resort & Spa in Carlsbad, California for its 18th International Antibody Development & Production conference on February 28 - March 2, 2007. This event has evolved into the most comprehensive three-day industry forum exploring every critical stage of process and product development. From the key decisions made during cell line development to the strategies implemented for efficient and economical large-scale production, this event is designed to help companies of all sizes accelerate their antibody therapeutic programs.

Program Highlights Include:

--  Keynote: Role of Technology and Science in Manufacturing Economics
    from Dr. S. Robert Adamson at Wyeth Biopharma
--  Keynote: Challenges of Designing an Antibody Manufacturing Facility
    for the 21st Century from Dr. Arleen Paulino at Amgen Inc.
--  Featured Presentation: Options to Overcome the Current Challenges in
    Downstream Processing from Wolfgang Berthold at Biogen Idec
--  Panel Discussion: The Future of Large Scale Chromatography
--  9 In-Depth Case Studies from Geneart AG, Biogen Idec, Serono
    Pharmaceutical Research Institute and Pfizer Global Biologics, Sartorius
    AG, Amgen, Bristol-Myers Squibb Company, Center D'Immunologie Peirre Fabre
    and PDF Biopharma, Inc.
In addition IBC has scheduled this event following the 11th International Process Validation for Biologicals, 2nd International Technology Transfer for Biopharmaceuticals and 3rd International Outsourcing Manufacturing of Biopharmaceuticals conferences giving attendees to opportunity for a full week of in-depth programming all under one roof.

Complete details on this event and the co-located conferences can be found at

About IBC Life Sciences

IBC Life Sciences is the worldwide leader in scientific, technological and business conferences and courses for the life science industry. To develop its programs, IBC actively researches the advancements, technologies and trends impacting and driving the race for new drugs and therapies. No other organization can make claim to the breadth and quality that IBC Life Sciences delivers in each event giving the company recognition around the globe for quality, service and value. For more information, visit:

Contact Information